More tax exemptions and incentives set for innovative pharmaceutical firms

Published: 2011-03-08 06:59:00

Updated: 2011-03-08 06:59:00

With the domestic industry promotion law passed Friday, Korea will seek to expand tax exemptions for innovative pharmaceutical companies as part of efforts to stimulate state-run and private companies’ research and development (R&D) spending in the era of free trade agreements (FTAs).

In parti...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK